https://peptidepolicywatch.com/2026/11/02/proprietary-blend-supplement-label-what-it-can-hide/Peptide Policy Watchen2026-11-02Proprietary blend on a supplement label: what it tells you and what it can leave out https://peptidepolicywatch.com/2026/11/02/oxytocin-first-synthetic-peptide-hormone-pitocin/Peptide Policy Watchen2026-11-02Oxytocin: the first peptide hormone made in a lab, and the medicine it became https://peptidepolicywatch.com/2026/11/02/anti-aging-longevity-peptide-claims-fda-ftc-rules/Peptide Policy Watchen2026-11-02Anti-aging and longevity peptide claims: what FDA and FTC rules actually say https://peptidepolicywatch.com/2026/11/02/2020-polypeptide-change-biologics-transition-40-amino-acids/Peptide Policy Watchen2026-11-02The 2020 "polypeptide" change: why insulin became a biologic and most peptides stayed drugs https://peptidepolicywatch.com/2026/11/01/weekly-hhs-six-peptide-policy-published/Peptide Policy Watchen2026-11-01Peptide Week in 5 minutes: HHS opens a door for six peptides (October 26 to November 1, 2026) https://peptidepolicywatch.com/2026/11/01/natural-vs-synthetic-peptides-what-naturally-occurring-means/Peptide Policy Watchen2026-11-01"Naturally occurring" peptides: what the phrase tells you, and what it leaves out https://peptidepolicywatch.com/2026/11/01/cgmp-certificate-of-analysis-peptides-what-they-mean/Peptide Policy Watchen2026-11-01CGMP and certificates of analysis: the quality paperwork at the center of HHS's peptide policy